StonvexLoading…
StonvexCore line items from PDM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $564.99M | $570.32M | $577.76M | $563.77M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $-83.62M | $-79.07M | $-48.39M | $146.83M |
EPS (Diluted) | $-0.67 | $-0.64 | $-0.39 | $1.19 |
Total Assets | $4.03B | $4.11B | $4.06B | $4.09B |
Total Liabilities | $2.53B | $2.53B | $2.33B | $2.24B |
Cash & Equivalents | $731.00K | $109.64M | $825.00K | $16.54M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 124.52M | 124.08M | 123.72M | 123.44M |